Resources
Big Molecule Watch
- Celltrion Submits BLA for Omalizumab Biosimilar March 18, 2024 Alison Siedor
- Fresenius Kabi Announces FDA Approval of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA March 15, 2024 Sam Herron
- FDA Approves Sandoz Denosumab Biosimilars March 8, 2024 Emma Murray
- Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar March 7, 2024 Emma Murray
- Biocon Settles with Janssen, Securing U.S. Market Entry Date for Ustekinumab Biosimilar March 7, 2024 Emma Murray
- Teva and Alvotech’s Adalimumab Biosimilar Receives Interchangeable Status at FDA March 5, 2024 Jonathan Rankin
- Court Grants Summary Judgment Ending AstraZeneca’s Lawsuit Challenging the IRA March 1, 2024 Alexandra Lu
- Post-Trial Updates on Regeneron v. Mylan (Aflibercept) BPCIA Litigation March 1, 2024 Grace Truong
- Genentech and Partners Voluntarily Dismiss IPR Appeals Related to Genentech’s ACTEMRA® (Tocilizumab) March 1, 2024 Christopher Cassella
- Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK in Lupus Nephritis February 29, 2024 Stephanie Dusaban Gonzales
BioPharma Reporter
- Eli Lilly strikes deal with Amazon: Will the ecommerce giant become go-to destination for GLP-1s? March 18, 2024
- Clene’s neurodegenerative disease drug shows promise with new study publication March 18, 2024
- ReciBioPharma to advance haemophilia treatment with GeneVentiv Therapeutics March 18, 2024
- DP World launches 100 worldwide freight forwarding offices to boost healthcare logistics March 15, 2024
- AstraZeneca’s $1.05 billion takeover of Amolyt shines spotlight on rare disease research March 15, 2024
- Investors pile onto ADCs in Tubulis’ €128 million Series B2 March 15, 2024
- From a childhood fascination to a pull towards translational medicine, who is this week's Woman in Science? March 13, 2024
- How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients March 12, 2024
- Opdivo to face competition with Keytruda and Padcev combination in bladder cancer space March 12, 2024
- Adare Pharma Solutions expands oral dose capabilities in Europe March 12, 2024